SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-011974
Filing Date
2020-10-29
Accepted
2020-10-29 07:26:33
Documents
44
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plx-20200930x10q.htm   iXBRL 10-Q 929962
2 EX-31.1 plx-20200930xex31d1.htm EX-31.1 10031
3 EX-31.2 plx-20200930xex31d2.htm EX-31.2 10391
4 EX-32.1 plx-20200930xex32d1.htm EX-32.1 6096
5 EX-32.2 plx-20200930xex32d2.htm EX-32.2 6122
6 GRAPHIC plx-20200930x10q005.jpg GRAPHIC 54608
7 GRAPHIC plx-20200930x10q006.jpg GRAPHIC 74554
  Complete submission text file 0001558370-20-011974.txt   3453408

Data Files

Seq Description Document Type Size
8 EX-101.SCH plx-20200930.xsd EX-101.SCH 25170
9 EX-101.CAL plx-20200930_cal.xml EX-101.CAL 32367
10 EX-101.DEF plx-20200930_def.xml EX-101.DEF 88713
11 EX-101.LAB plx-20200930_lab.xml EX-101.LAB 208465
12 EX-101.PRE plx-20200930_pre.xml EX-101.PRE 175919
13 EXTRACTED XBRL INSTANCE DOCUMENT plx-20200930x10q_htm.xml XML 355178
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 201270522
SIC: 2836 Biological Products, (No Diagnostic Substances)